ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Novo Nordisk To Open Diabetes R&D Center

by Lisa M. Jarvis
January 30, 2012 | APPEARED IN VOLUME 90, ISSUE 5

Novo Nordisk is opening an R&D center in Seattle dedicated to accelerating the development of new treatments for type 1 diabetes. Slated to open this summer with about 20 scientists, the center will bring together at one site basic research and early proof-of-concept trials. Novo says this approach will enable new therapies to move quickly from animal models into human tests. Matthias von Herrath, currently director of the Center for Type 1 Diabetes Research at La Jolla Institute for Allergy & Immunology, will head the new center.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment